Kenya: As Parliament resumes next week, a newly published Bill to regulate the pharmaceutical industry is coming under criticism by experts who have highlighted loopholes that could hand a ‘rogue’ board undue influence in determining how the industry should be run.
The draft law limits access to essential drugs, they say. Consequently, the Kenya Pharmaceutical Association (KPA) has published a Bill Digest that it hopes it will enable Members of National Assembly to seal the loopholes and ambiguities they say if left in the current form, will be prone to abuse by the proposed regulatory body.